Get the Stockscreener App
11.62
19.59%
-2.88
Quantum Biopharma Ltd stock is traded at $11.62, with a volume of 2.54M.
It is down -19.59% in the last 24 hours and up +199.74% over the past month.
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.
See More
Previous Close:
$14.50
Open:
$12.57
24h Volume:
2.54M
Relative Volume:
1.19
Market Cap:
$27.83M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+274.92%
1M Performance:
+199.74%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$10.70
$13.58
1-Week Range:
$2.9745
$18.00
52-Week Range:
$2.70
$18.00
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Compare QNTM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
11.68 | 27.83M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
171.43 | 78.56B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.54 | 43.15B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.545 | 43.00B | 14.26B | 1.55B | 0 | 0.3383 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.61 | 19.59B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
123.48 | 15.24B | 2.24B | 385.90M | 440.10M | 3.73 |
Quantum Biopharma Ltd Stock (QNTM) Latest News
Top Small Cap Stocks To Research – February 04th - Armenian Reporter
Quantum BioPharma Heads For Best Week Ever — But Most Retail Traders Lament Missing Out On The Surge - Asianet Newsable
Quantum BioPharma Ltd’s Market Journey: Closing Strong at 14.50, Up 69.00 - The Dwinnex
Celly Nutrition targets IPO with $10 million capital raise - MSN
Quantum BioPharma Shares Are Up Over 80%: What's Going On? - Benzinga
Quantum Biopharma Stock Explodes 60% – Did Shorts Just Get ‘Unbuzzd’? - Wall Street Pit
How does Quantum BioPharma Ltd (QNTM) change from a tortoise to a hare? - SETE News
Celly Nutrition targets IPO with $10 million capital raise By Investing.com - Investing.com South Africa
Quantum BioPharma’s Licensee Celly Nutrition Plans IPO After Positive Trial Results - TipRanks
Quantum Biopharma Licensee Celly Nutrition Retains Leading - GlobeNewswire
Top Small Cap Stocks To ResearchFebruary 04th - MarketBeat
Quantum BioPharma (QNTM) Stock Soars 95% After Breakthrough Alcohol Metabolism Supplement Results - HPBL
Quantum BioPharma stock explodes 95%: Will it keep climbing? - Dataconomy
Quantum BioPharma soars on clinical trial success with ‘unbuzzd’ hangover cure supplement - Mugglehead
Quantum BioPharma stock soars on clinical trial success - MSN
Quantum BioPharma Shares Are Up Today: What's Going On? - Benzinga
Gold Moves Higher; Estée Lauder Shares Slide - Benzinga India
How analysts predict Quantum BioPharma Ltd (QNTM) will perform this quarter? - US Post News
Quantum BioPharma unbuzzd™ Clinical Trial Results Show Promising Benefits in Alcohol Intoxication and Hangover Relief – market - HPBL
Quantum BioPharma Shares Soar 95% Following Breakthrough Clinical Trial Results for unbuzzd™ - HPBL
Quantum BioPharma Soars 62% After Positive Clinical Trial Results for Unbuzzd Supplement - HPBL
Quantum BioPharma's Unbuzzd Proven to Accelerate Alcohol Metabolism in Clinical Trial; Shares Jump - Marketscreener.com
Quantum BioPharma Stock Is Soaring Tuesday: What's Driving The Action? - Benzinga
Pre-Market Boost For Quantum BioPharma (QNTM) As Clinical Results Impress Investors - Stocks Telegraph
Quantum BioPharma’s unbuzzd™ Shows Promising Results in Clinical Trial - TipRanks
Top Premarket Gainers -February 04, 2025 at 07:32 am EST - Marketscreener.com
Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial - The Manila Times
Quantum Biopharma Ltd. Announces the Success of Unbuzzd Clinical Trial -February 04, 2025 at 07:03 am EST - Marketscreener.com
Quantum BioPharma Ltd - Stockhouse Publishing
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Is ‘One to Watch’ - The Globe and Mail
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Is ‘One To Watch’ - Barchart
Quantum Biopharma Announces Celly Nutrition Launches unbuzzd(TM) Grab-and-Go Stick Packs on Amazon.com so you can "own NOW and what’s NEXT" - ACCESS Newswire
Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update - ACCESS Newswire
Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia - ACCESS Newswire
Schrödinger, Inc. (SDGR): Quantum Mechanics Meets AI in Biopharma, Backed by Hunterbrook’s ‘Key AI Winner’ Endorsement - Yahoo Finance
Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates - ACCESS Newswire
Quantum Biopharma Announces Closing of Second Tranche - ACCESS Newswire
Contrasting Quantum Biopharma (NASDAQ:QNTM) & ASLAN Pharmaceuticals (NASDAQ:ASLN) - Defense World
Quantum BioPharma Closes Third Tranche Offering with Amended Terms - TipRanks
Quantum Biopharma Announces Closing of Third Tranche - Newsfile
Quantum Biopharma in Court With Dr. Raza Bokhari on January 24 - WICZ
Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM - ACCESS Newswire
Quantum BioPharma Advances Legal Actions Against Former CEO - TipRanks
Quantum BioPharma begins trading on Upstream a By Investing.com - Investing.com Nigeria
Quantum BioPharma Expands Global Reach with Upstream Listing - TipRanks
Quantum BioPharma begins trading on Upstream a - Investing.com
Quantum BioPharma Expands Global Reach with Upstream Exchange Dual Listing for 2025 - StockTitan
Quantum Biopharma approved to dual list on Upstream - MSN
Quantum BioPharma to Dual List on Upstream - TipRanks
Quantum BioPharma to list on Upstream trading platform - Investing.com
Quantum Biopharma Ltd. Approved to Dual List on Upstream - AccessWire
Quantum Biopharma Ltd Stock (QNTM) Financials Data
There is no financial data for Quantum Biopharma Ltd (QNTM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.05%
2.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):